Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2005 1
2006 2
2008 2
2009 1
2010 1
2011 1
2020 1
2021 9
2022 11
2023 10
2024 8
2025 10
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
ADAMTS-7 Modulates Atherosclerotic Plaque Formation by Degradation of TIMP-1.
Sharifi MA, Wierer M, Dang TA, Milic J, Moggio A, Sachs N, von Scheidt M, Hinterdobler J, Müller P, Werner J, Stiller B, Aherrahrou Z, Erdmann J, Zaliani A, Graettinger M, Reinshagen J, Gul S, Gribbon P, Maegdefessel L, Bernhagen J, Sager HB, Mann M, Schunkert H, Kessler T. Sharifi MA, et al. Among authors: zaliani a. Circ Res. 2023 Sep 29;133(8):674-686. doi: 10.1161/CIRCRESAHA.123.322737. Epub 2023 Sep 7. Circ Res. 2023. PMID: 37675562 Free PMC article.
Identification and development of TRPM4 antagonists to counteract neuronal excitotoxicity.
Binkle-Ladisch L, Pironet A, Zaliani A, Alcouffe C, Mensching D, Haferkamp U, Willing A, Woo MS, Erdmann A, Jessen T, Hess SD, Gribbon P, Pless O, Vennekens R, Friese MA. Binkle-Ladisch L, et al. Among authors: zaliani a. iScience. 2024 Nov 19;27(12):111425. doi: 10.1016/j.isci.2024.111425. eCollection 2024 Dec 20. iScience. 2024. PMID: 39687019 Free PMC article.
Development of a Potent and Selective G2A (GPR132) Agonist.
Hernandez-Olmos V, Heering J, Marinescu B, Schermeng T, Ivanov VV, Moroz YS, Nevermann S, Mathes M, Ehrler JHM, Alnouri MW, Wolf M, Haydo AS, Schmachtel T, Zaliani A, Höfner G, Kaiser A, Schubert-Zsilavecz M, Beck-Sickinger AG, Offermanns S, Gribbon P, Rieger MA, Merk D, Sisignano M, Steinhilber D, Proschak E. Hernandez-Olmos V, et al. Among authors: zaliani a. J Med Chem. 2024 Jul 11;67(13):10567-10588. doi: 10.1021/acs.jmedchem.3c02164. Epub 2024 Jun 25. J Med Chem. 2024. PMID: 38917049 Free PMC article.
The fast-dissociating D2 antagonist antipsychotic JNJ-37822681 is a neuronal Kv7 channel opener: Potential repurposing for epilepsy treatment.
Carotenuto L, Keminer O, Carleo G, Zaliani A, Leo A, Citraro R, De Sarro G, Dirkx N, Kaji M, Weckhuysen S, Reinshagen J, Barrese V, Guida N, Ostacolo C, Miceli F, Gribbon P, Taglialatela M. Carotenuto L, et al. Among authors: zaliani a. Br J Pharmacol. 2025 Nov;182(22):5574-5595. doi: 10.1111/bph.70119. Epub 2025 Jul 23. Br J Pharmacol. 2025. PMID: 40702669
Exploring SureChEMBL from a drug discovery perspective.
Gadiya Y, Shetty S, Hofmann-Apitius M, Gribbon P, Zaliani A. Gadiya Y, et al. Among authors: zaliani a. Sci Data. 2024 May 16;11(1):507. doi: 10.1038/s41597-024-03371-4. Sci Data. 2024. PMID: 38755219 Free PMC article.
Selection of data sets for FAIRification in drug discovery and development: Which, why, and how?
Alharbi E, Gadiya Y, Henderson D, Zaliani A, Delfin-Rossaro A, Cambon-Thomsen A, Kohler M, Witt G, Welter D, Juty N, Jay C, Engkvist O, Goble C, Reilly DS, Satagopam V, Ioannidis V, Gu W, Gribbon P. Alharbi E, et al. Among authors: zaliani a. Drug Discov Today. 2022 Aug;27(8):2080-2085. doi: 10.1016/j.drudis.2022.05.010. Epub 2022 May 17. Drug Discov Today. 2022. PMID: 35595012 Free PMC article. Review.
57 results